Drug Breakdown: METOLAZONE

02 April 2025
Volume 7 · Issue 4
blister packs or prescription pads

Abstract

In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of posts on Bluesky. This month she is talking about #metolazone

Dr Sharon Rees @reesprescribe

Day 1: A potent long-acting oral thiazide-like diuretic, #metolazone was discovered in the 1970s. Can be used in combination with loop diuretics for acute heart failure where it may potentiate effect & is postulated to help with diuretic resistance. Mostly used short-term, but some require longterm management

Dr Sharon Rees @reesprescribe

Day 2: #metolazone is licensed in adults for oedema of heart failure or kidney disease, as well as hypertension. Licensed in the UK as Xaqua® as 5 mg divisible tablet (care re switching as imports had other strengths/differences in bioavailability). Dose is 2.5 to 5 mg daily a.m.

Dr Sharon Rees @reesprescribe

Day 3: #metolazone has good oral absorption;take same time daily relative to meal;cmax~1.5hrs. High Vd & protein binding. ~ 10% hydroxylated to inactive metabolites/some enterohepatic recycling. Most excreted unchanged in urine/ small % biliary excretion. T½ 8-10hrs. Note that states of oedema can affect bioavailability for #metolazone; monitor for response variability

Dr Sharon Rees @reesprescribe

Day 4: #metolazone inhibits NaCl symporter & thus Na reabsorption. The action is predominantly in distal tubule, increasing urine volume & reducing fluid accumulation. Also, some Na absorption inhibition occurs in proximal tubule. K+excretion may be less affected compared to other diuretics. #metolazone is believed not to induce the reninangiotensin-aldosterone system, which supports overcoming issues with diuretic resistance. Electrolyte monitoring required

Dr Sharon Rees @reesprescribe

Day 5: Adverse drugs effects for #metolazone: constipation, raised uric acid, glycosuria, electrolyte disturbances, hypotension/falls in elderly. Avoid in pregnancy. Has low renal toxicity with efficacy @lower GFRs (<30); can be used in impaired renal function (caution if severe) (NOT exhaustive)

Dr Sharon Rees @reesprescribe

Day 6: Most ‘severe’ drug-drug interactions relate to hypokalaemia e.g aripiprazole, citalopram, or the risk of renal failure e.g NSAIDs. #metolazone can also increase the concentration of lithium. Many DDIs also increase risk of hypotension e.g alcohol, other antihypertensives (NOT exhaustive)

Dr Sharon Rees @reesprescribe

Day 7: Having similar characteristics to the thiazide family of drugs, #metolazone is a quinazoline-sulfonamide; therefore there is a risk of allergic reaction in cases of sulfonamide allergy, albeit a lower risk than for sulfonamide antibiotics

Earn Your CPD Certificate

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate

In addition to the posts, read the BNF 1 monograph on metolazone and the related treatment summary on ‘Diuretics’. Another useful source is the Summary of Product Characteristics for Xaqua®. See links below. Once you have completed this, answer the 10 questions. Submit your answers to reesprescribe@gmail.com. If you answer at least eight out of 10 questions correctly, you will receive your CPD certificate via email.

  • Metolazone is a short-acting diuretic TRUE or FALSE?
  • Metolazone has many formulations TRUE or FALSE?
  • Metolazone is licensed for oedema and hypertension in adults TRUE or FALSE?
  • Which of the following is TRUE?
  • Metolazone can be used in combination with loop diuretics
  • Metolazone is usually combined with other thiazide diuretics
  • Metolazone should not be combined with any other diuretics
  • Metolazone has only one dose option
  • Care is needed with metolazone use, as there can be response variability related to both oedema levels and the preparation used TRUE or FALSE?
  • Which of the following is TRUE?
  • Metolazone acts only in the distal tubule of the nephron
  • Metolazone acts to inhibit the Na K+ symporters in the proximal tubule of the nephron
  • Metolazone acts to inhibit the NaCl symporters in the distal and proximal tubules of the nephron
  • Metolazone acts to inhibit the Na, Mg, K+ symporters in the distal and proximal tubules of the nephron
  • Advantages of metolazone include efficacy in the presence of renal impairment TRUE or FALSE?
  • Metolazone can cause gout and constipation TRUE or FALSE?
  • Which of the following is FALSE regarding metolazone interactions?
  • There are severe DDIs with NSAIDs
  • There is a mild DDI with lithium
  • There are several DDIs with drugs which precipitate hypotension
  • There are some severe DDIs relating to potentiation of hypokalaemia
  • A sulfonamide allergy may cause hypersensitivity when using metolazone TRUE or FALSE?
  • Further reading on #methenamine

  • https://bnf.nice.org.uk/drugs/metolazone/
  • https://bnf.nice.org.uk/treatmentsummaries/diuretics/
  • https://www.medicines.org.uk/emc/product/13419/smpc#gref